AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

BAX · NYSE · Medical - Instruments & Supplies

Baxter International (BAX)

Supplies hospital infusion, connected-care, surgical, respiratory, and injectable medicine products.

$23.73

vs last close+0.05 (+0.21%)

In millions of USD, except per-share figures

In millions	Q3 FY23Sep 2023	Q4 FY23Dec 2023	Q1 FY24Mar 2024	Q2 FY24Jun 2024	Q3 FY24Sep 2024	Q4 FY24Dec 2024	Q1 FY25Mar 2025	Q2 FY25Jun 2025	Q3 FY25Sep 2025	Q4 FY25Dec 2025	Q1 FY26Mar 2026	Q2 FY26Jun 2026
Revenue	2,599	3,885	2,490	2,694	2,699	2,753	2,625	2,810	2,835	2,974	2,701	2,960
Cost of revenue	1,543	2,413	1,529	1,663	1,666	1,794	1,764	1,819	1,885	2,397	1,810	1,928
Gross profit	1,056	1,472	961	1,031	1,033	959	861	991	950	577	891	1,032
	877	1,143	846	852	878	1,394	803	800	778	1,306	825	815
Research & development	133	172	120	130	129	211	140	134	118	126	139	129
	744	977	729	723	754	761	703	718	708	761	728	735
Selling & marketing	0	0	−266	0	0	0	0	0	0	0	0	0
General & administrative	0	0	995	0	0	0	0	0	0	0	728	735
Other expenses	0	−6	−3	−1	−5	422	−40	−52	−48	419	−42	−49
Operating income	179	329	115	179	155	−435	58	191	172	−729	66	217
	−115	−91	−69	−62	−86	−86	−61	−58	−51	−27	−72	−59
Interest income	9	44	25	18	14	10	17	14	10	11	12	13
Interest expense	136	117	103	104	101	100	81	72	68	69	78	77
Other non-operating income	−21	−26	−34	−42	−15	−14	−20	−14	−17	−42	6	−18
Income before tax	64	238	46	117	69	−521	−3	133	121	−756	−6	158
Income tax expense	27	165	40	22	8	−33	−67	11	172	279	11	23
Net income from continuing operations	37	73	6	95	61	−488	64	122	−51	−1,035	−17	135
Discontinued operations	2,474	173	33	−406	83	−22	62	−31	5	−93	2	−9
Net income	2,508	245	37	−314	140	−512	126	91	−46	−1,128	−15	126
EPS, basic	$4.95	$0.48	$0.07	−$0.61	$0.28	−$1.00	$0.25	$0.18	−$0.09	−$2.16	−$0.03	$0.24
EPS, diluted	$4.93	$0.48	$0.07	−$0.61	$0.27	−$1.00	$0.25	$0.18	−$0.09	−$2.16	−$0.03	$0.24
Weighted average shares, basic	507	507	508	510	510	510	512	513	514	514	515	517
Weighted average shares, diluted	507	507	510	510	512	510	514	514	514	514	515	518
EBITDA	292	679	420	448	424	−176	325	462	426	−447	297	474
Depreciation & amortization	92	324	271	227	254	245	247	257	237	240	237	239
EBIT	200	355	149	221	170	−421	78	205	189	−687	60	235